Fever After Lung Cancer Chemotherapy and Delayed Recognition of Febrile Neutropenia

Most people on chemotherapy are told to call if they get a fever. Fewer are told how little time they may have once it appears.

For someone with a weakened immune system, a temperature of 100.4°F can be the first, and sometimes the only, warning that a dangerous infection is taking hold. When that warning is brushed off, delayed, or lost in a phone tree, a treatable complication can become sepsis.

This article explains what febrile neutropenia is, why lung cancer patients face particular risk, where delays tend to happen, and when a delay may be malpractice under New York law.

What Febrile Neutropenia Is

Febrile neutropenia is a fever combined with a dangerously low count of neutrophils, the white blood cells that are the body’s first defense against bacterial infection. Chemotherapy attacks fast-dividing cells, including the bone marrow cells that make neutrophils.

The American Society of Clinical Oncology and the Infectious Diseases Society of America define the fever as a single oral temperature of 101°F (38.3°C) or higher, or 100.4°F (38.0°C) or higher sustained over an hour. Neutropenia generally means an absolute neutrophil count below 500 per microliter, or below 1,000 with a drop to 500 expected within about 48 hours.

Neutrophils also produce the visible signs of infection, such as pus, swelling, and redness. Without them, a seriously infected person may look only mildly ill, with fever as the lone red flag. That’s why guidelines treat fever in a neutropenic patient as an emergency until proven otherwise.

When Fever Usually Strikes

Neutrophil counts usually bottom out about 7 to 14 days after a chemotherapy cycle, a low point called the nadir. Timing varies by drug and by person. A fever in that window should be treated as possible febrile neutropenia. Waiting to see whether it passes overnight doesn’t fit this situation. Calling right away, at any hour, is exactly what oncology teams want.

Many teams also tell patients not to take acetaminophen or ibuprofen before calling, because fever reducers can hide the one symptom that signals danger. Confirm what your own team wants you to do.

Why Lung Cancer Patients Face Particular Risk

Lung cancer treatment raises the odds in several ways:

• Small cell lung cancer is often treated with platinum drugs plus etoposide, which hit the bone marrow hard. Second-line topotecan carries a high risk.

• Non-small cell lung cancer is commonly treated with platinum pairings such as carboplatin with paclitaxel, and with docetaxel, which is well known for causing severe neutrophil drops.

• Combined treatment compounds the effect on blood counts, whether that’s chemotherapy with immunotherapy or with chest radiation.

The patients themselves are often more vulnerable. Many are older and have COPD or other lung disease, poor nutrition, or low baseline counts. A port or central line adds another way for bacteria to enter the bloodstream.

Oncology guidelines sort regimens by febrile neutropenia risk, typically as high (above 20%), intermediate (10% to 20%), or low (below 10%). For higher-risk regimens, doctors are expected to consider preventive growth factor injections such as filgrastim or pegfilgrastim. Whether that conversation happened, and whether the reasoning was documented, can matter later. Our page on cancer treatments gives background on chemotherapy.

What Should Happen When a Chemo Patient Reports a Fever

The accepted response is well established. Once the patient reaches care, the team is expected to:

• Check vital signs and screen for sepsis

• Order a complete blood count with differential to measure neutrophils

• Draw blood cultures, including from any central line

• Start broad-spectrum IV antibiotics, usually an anti-pseudomonal drug such as cefepime or piperacillin-tazobactam, without waiting for culture results

Under the ASCO/IDSA guideline, the first dose of antibiotics should be given within one hour of triage. Cultures shouldn’t hold up antibiotics. Doctors use risk tools such as the MASCC index to decide who can be treated as an outpatient and who must be admitted. Lung cancer patients with COPD or other serious conditions often land in the higher-risk group.

Chest imaging is part of the workup when there are respiratory symptoms. But an early X-ray can look normal in a profoundly neutropenic patient, because the body can’t mount its usual response. A normal first image doesn’t rule out pneumonia.

Where Delays Happen

Delays rarely come from one dramatic mistake. They build from smaller failures across the system.

Before the fever. Patients should leave their first chemotherapy visit knowing how to take their temperature, what number counts as a fever, and which 24-hour line to call. A patient never given a clear threshold, or a number that works at 2 a.m., is already at a disadvantage.

On the phone. A nurse or answering service may tell a feverish patient to take Tylenol and call back in the morning. Without a documented triage protocol that treats a chemotherapy patient’s fever as urgent, a call that should have sent someone to the emergency room sends them back to bed.

In the emergency department. A cancer patient with a fever may sit in the waiting room without being flagged. A department with no neutropenic fever pathway may delay the blood count or cultures, or blame a virus or a treatment side effect without checking neutrophils. Antibiotics may start late, may be too narrow, or may not be escalated as the patient worsens.

Elsewhere in the chain. A high-risk regimen may be given without growth factor support and without a documented reason. Abnormal labs may go unaddressed. Infection at a port site may be missed. An after-hours call may never reach the oncologist on call.

How Dangerous It Is

A large University of Rochester-led study in Cancer followed 41,779 adults hospitalized with febrile neutropenia. It found in-hospital mortality of 9.5% overall. The rate was 2.6% for patients with no major comorbidities and 21.4% or higher for those with more than one. These are population figures, not a prediction for any one person.

Research on antibiotic timing is still evolving. Many studies link longer delays to worse outcomes, particularly once sepsis develops, but the findings aren’t uniform. That matters legally, because the connection between a specific delay and a specific outcome has to be proven with expert testimony, not assumed.

When a Delay Becomes Malpractice in New York

A bad outcome alone isn’t enough. Fever after chemotherapy has many causes, and not every delay changes the result. A New York claim requires proving two things.

A departure from accepted practice. This could be:

• A triage nurse who dismissed a clear fever report

• An emergency department that didn’t draw cultures or give antibiotics in a reasonable time

• An oncology practice that never gave fever instructions

• A hospital that ignored its own written protocols

Causation. The departure must have been a substantial factor in causing harm, and this is usually the harder part. The defense will often argue the patient’s advanced lung cancer, or the infection itself, would have produced the same outcome regardless. It may also argue the fever came from something else, such as pneumonitis, an immunotherapy reaction, or the tumor. New York courts have allowed claims where negligence took away a meaningful chance at a better outcome, even when the patient was already seriously ill. How that applies depends heavily on the medical evidence.

These cases require expert review, and a complaint must be filed with a certificate of merit.

Who Can Be Responsible

Liability can reach more than one party:

• Hospitals are generally responsible for their employed doctors and nurses. Under New York’s apparent agency doctrine, a hospital can also answer for an independent emergency physician when the patient reasonably believed the doctor was acting for the hospital. A hospital can also be directly negligent, for example through missing triage protocols, understaffing, or ignoring its own policies.

• Oncology practices can be responsible for patient education, how their after-hours phone system works, and how they managed the risk of low blood counts.

New York also has sepsis rules of its own. After the death of 12-year-old Rory Staunton, the state in January 2013 became the first to require hospitals to adopt evidence-based sepsis protocols, known as Rory’s Regulations. The rules cover screening, early treatment, staff training, and reporting to the Department of Health. A 2019 JAMA study found that adjusted sepsis mortality in New York fell 3.2 percentage points below what was expected after the rules took effect. Febrile neutropenia and sepsis overlap but aren’t identical. Still, a hospital’s compliance with its own sepsis procedures can be important evidence.

New York’s Filing Deadlines

Under CPLR 214-a, a malpractice lawsuit generally must be filed within two years and six months of the negligent act or omission. Because this is a treatment complication rather than a missed cancer diagnosis, the special discovery rule for failure-to-diagnose-cancer claims (Lavern’s Law) generally doesn’t apply. The continuous treatment doctrine may pause the clock while a patient keeps receiving care from the same provider for the same condition. Whether it applies is fact-specific and often contested.

If a patient dies, a wrongful death claim generally must be filed within two years of the date of death. We explain how these claims work in our article on wrongful death after a missed lung cancer. Claims against public hospitals, including NYC Health + Hospitals, require a notice of claim within 90 days. Families who assume they have years can lose their rights quickly.

Evidence to Keep

Records often decide these cases.

At home:

• Fever readings with dates and times

• Notes on every symptom and every phone call, including who you spoke with and what they said

• Portal messages, voicemails, and texts

• Chemotherapy education handouts and discharge instructions, which show whether a fever threshold and 24-hour number were ever given

From the hospital:

• Timestamps for arrival, triage, the blood count, the cultures, and the first antibiotic dose. The antibiotic time comes from the medication administration record.

• Lab trends, including neutrophil count, lactate, and culture results

• Sepsis screening documentation

Public Health Law § 18 gives you the right to request the complete chart.

Questions to Ask Before Your Next Cycle

• What temperature should make me call?

• What number do I call at night and on weekends, and who answers?

• Should I go straight to the emergency room, and which one?

• Is my regimen high-risk for low white counts, and should I get a growth factor injection?

• Can you give me a letter or wallet card saying I’m on chemotherapy?

Know the other warning signs too:

• Shaking chills, especially around a port flush

• A new cough or shortness of breath

• A sore throat or mouth sores

• Burning with urination

• Diarrhea

• Redness or drainage at a port site

• Sudden confusion or feeling suddenly very unwell

If any of these appear, call or go to the emergency room. Tell triage right away that you’re on chemotherapy and may have low white blood cell counts.

Our article on preventing infections in immunosuppressed cancer patients covers day-to-day precautions.

Talk With a New York Cancer Lawyer

If you or someone you love developed a serious infection, sepsis, or a worse outcome after a fever during lung cancer treatment, you don’t have to work out what went wrong alone. Porter Law Group represents patients and families across New York, with offices in Albany, Buffalo, New York City, Rochester, and Syracuse. Our New York cancer lawyers work with oncology, infectious disease, and emergency medicine experts to review the timeline and records. For more on lung cancer claims, see our lung cancer malpractice overview and our results in cancer cases.

Call 833-888-LATE, email info@porterlawteam.com, or request a free case evaluation.

Attorney advertising. This article provides general information and is not legal or medical advice. If you have a fever during chemotherapy, contact your oncology team or go to the emergency room now. Prior results do not guarantee a similar outcome. Filing deadlines depend on the facts of each case.

Frequently Asked Questions

What temperature counts as a fever during chemotherapy?

Under ASCO and IDSA guidance, a fever in a patient who may be neutropenic is a single oral temperature of 101°F (38.3°C) or higher, or 100.4°F (38.0°C) or higher lasting at least an hour. Your oncology team may give you a specific number. If you reach it, call right away rather than waiting overnight.

How quickly should antibiotics be given for neutropenic fever?

The ASCO and IDSA guideline says the first dose of broad-spectrum IV antibiotics should be given within one hour of triage. Blood cultures should be drawn first, but they shouldn’t delay treatment. Without neutrophils, infections can progress quickly, so fever in a chemotherapy patient is treated as an emergency until proven otherwise.

When is neutropenic fever most likely after chemotherapy?

Neutrophil counts usually reach their lowest point, called the nadir, about 7 to 14 days after a chemotherapy cycle, though timing varies by drug and patient. A fever during that window should be treated as possible febrile neutropenia. Many teams advise against taking fever reducers before calling, because they can mask the warning sign.

Can I sue a hospital for delaying treatment of neutropenic fever in New York?

Possibly. A claim may exist if a triage nurse dismissed a fever report, an emergency department delayed cultures or antibiotics, or a hospital ignored its own protocols. You must also show the delay was a substantial factor in causing harm, such as sepsis or death, which requires expert testimony. Hospitals can be liable for staff and sometimes independent physicians.

What is the deadline to file a chemotherapy complication claim in New York?

Most medical malpractice claims must be filed within two years and six months of the negligent act, though continuous treatment can pause the clock. Lavern’s Law generally doesn’t apply, because this isn’t a missed cancer diagnosis. Wrongful death claims must be filed within two years of death, and public hospital claims require a notice within 90 days.